1-1 of 1
Yair Molad, MD
Close
Sort by
Journal Articles

Anti-CD20 Monoclonal Antibody (Rituximab) as an Optional Treatment for Intractable Acquired Glanzmann’s Thrombasthenia.

Dorit Blickstein, MD, Judith Lahav, PhD, Yair Molad, MD, Aida Inbal, MD
Journal: Blood
Blood (2006) 108 (11): 3971.
https://doi.org/10.1182/blood.V108.11.3971.3971
Published: 2006